159 related articles for article (PubMed ID: 19331675)
1. The second Symptom Management Research Trial in Oncology (SMaRT Oncology-2): a randomised trial to determine the effectiveness and cost-effectiveness of adding a complex intervention for major depressive disorder to usual care for cancer patients.
Walker J; Cassidy J; Sharpe M;
Trials; 2009 Mar; 10():18. PubMed ID: 19331675
[TBL] [Abstract][Full Text] [Related]
2. The third symptom management research trial in oncology (SMaRT oncology-3): a randomised trial to determine the efficacy of adding a complex intervention for major depressive disorder (depression care for people with lung cancer) to usual care, compared to usual care alone in patients with lung cancer.
Walker J; Cassidy J; Sharpe M;
Trials; 2009 Sep; 10():92. PubMed ID: 19793390
[TBL] [Abstract][Full Text] [Related]
3. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT.
Serfaty M; King M; Nazareth I; Moorey S; Aspden T; Tookman A; Mannix K; Gola A; Davis S; Wood J; Jones L
Health Technol Assess; 2019 May; 23(19):1-106. PubMed ID: 31097078
[TBL] [Abstract][Full Text] [Related]
4. Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): a multicentre randomised controlled trial in patients with lung cancer.
Walker J; Hansen CH; Martin P; Symeonides S; Gourley C; Wall L; Weller D; Murray G; Sharpe M;
Lancet Oncol; 2014 Sep; 15(10):1168-76. PubMed ID: 25175097
[TBL] [Abstract][Full Text] [Related]
5. CASPER plus (CollAborative care in Screen-Positive EldeRs with major depressive disorder): study protocol for a randomised controlled trial.
Overend K; Lewis H; Bailey D; Bosanquet K; Chew-Graham C; Ekers D; Gascoyne S; Hems D; Holmes J; Keding A; McMillan D; Meer S; Meredith J; Mitchell N; Nutbrown S; Parrott S; Richards D; Traviss G; Trépel D; Woodhouse R; Gilbody S
Trials; 2014 Nov; 15(1):451. PubMed ID: 25409776
[TBL] [Abstract][Full Text] [Related]
6. The clinical and cost effectiveness of cognitive behavioural therapy plus treatment as usual for the treatment of depression in advanced cancer (CanTalk): study protocol for a randomised controlled trial.
Serfaty M; King M; Nazareth I; Tookman A; Wood J; Gola A; Aspden T; Mannix K; Davis S; Moorey S; Jones L
Trials; 2016 Feb; 17(1):113. PubMed ID: 26926910
[TBL] [Abstract][Full Text] [Related]
7. Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial.
Sharpe M; Walker J; Holm Hansen C; Martin P; Symeonides S; Gourley C; Wall L; Weller D; Murray G;
Lancet; 2014 Sep; 384(9948):1099-108. PubMed ID: 25175478
[TBL] [Abstract][Full Text] [Related]
8. CollAborative care for Screen-Positive EldeRs with major depression (CASPER plus): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness.
Bosanquet K; Adamson J; Atherton K; Bailey D; Baxter C; Beresford-Dent J; Birtwistle J; Chew-Graham C; Clare E; Delgadillo J; Ekers D; Foster D; Gabe R; Gascoyne S; Haley L; Hamilton J; Hargate R; Hewitt C; Holmes J; Keding A; Lewis H; McMillan D; Meer S; Mitchell N; Nutbrown S; Overend K; Parrott S; Pervin J; Richards DA; Spilsbury K; Torgerson D; Traviss-Turner G; Trépel D; Woodhouse R; Gilbody S
Health Technol Assess; 2017 Nov; 21(67):1-252. PubMed ID: 29171379
[TBL] [Abstract][Full Text] [Related]
9. Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial.
Wiles N; Thomas L; Abel A; Barnes M; Carroll F; Ridgway N; Sherlock S; Turner N; Button K; Odondi L; Metcalfe C; Owen-Smith A; Campbell J; Garland A; Hollinghurst S; Jerrom B; Kessler D; Kuyken W; Morrison J; Turner K; Williams C; Peters T; Lewis G
Health Technol Assess; 2014 May; 18(31):1-167, vii-viii. PubMed ID: 24824481
[TBL] [Abstract][Full Text] [Related]
10. Management of depression for people with cancer (SMaRT oncology 1): a randomised trial.
Strong V; Waters R; Hibberd C; Murray G; Wall L; Walker J; McHugh G; Walker A; Sharpe M
Lancet; 2008 Jul; 372(9632):40-8. PubMed ID: 18603157
[TBL] [Abstract][Full Text] [Related]
11. Guided self-help for depression in autistic adults: the ADEPT feasibility RCT.
Russell A; Gaunt D; Cooper K; Horwood J; Barton S; Ensum I; Ingham B; Parr J; Metcalfe C; Rai D; Kessler D; Wiles N
Health Technol Assess; 2019 Dec; 23(68):1-94. PubMed ID: 31856942
[TBL] [Abstract][Full Text] [Related]
12. CollAborative care and active surveillance for Screen-Positive EldeRs with subthreshold depression (CASPER): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness.
Lewis H; Adamson J; Atherton K; Bailey D; Birtwistle J; Bosanquet K; Clare E; Delgadillo J; Ekers D; Foster D; Gabe R; Gascoyne S; Haley L; Hargate R; Hewitt C; Holmes J; Keding A; Lilley-Kelly A; Maya J; McMillan D; Meer S; Meredith J; Mitchell N; Nutbrown S; Overend K; Pasterfield M; Richards D; Spilsbury K; Torgerson D; Traviss-Turner G; Trépel D; Woodhouse R; Ziegler F; Gilbody S
Health Technol Assess; 2017 Feb; 21(8):1-196. PubMed ID: 28248154
[TBL] [Abstract][Full Text] [Related]
13. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and cost-effectiveness of transmural collaborative care with consultation letter (TCCCL) and duloxetine for major depressive disorder (MDD) and (sub)chronic pain in collaboration with primary care: design of a randomized placebo-controlled multi-Centre trial: TCC:PAINDIP.
de Heer EW; Dekker J; van Eck van der Sluijs JF; Beekman AT; van Marwijk HW; Holwerda TJ; Bet PM; Roth J; Hakkaart-Van Roijen L; Ringoir L; Kat F; van der Feltz-Cornelis CM
BMC Psychiatry; 2013 May; 13():147. PubMed ID: 23705849
[TBL] [Abstract][Full Text] [Related]
15. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
[TBL] [Abstract][Full Text] [Related]
16. Randomised controlled trial of the clinical and cost effectiveness of a specialist team for managing refractory unipolar depressive disorder.
Morriss R; Marttunnen S; Garland A; Nixon N; McDonald R; Sweeney T; Flambert H; Fox R; Kaylor-Hughes C; James M; Yang M
BMC Psychiatry; 2010 Nov; 10():100. PubMed ID: 21114826
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression.
Bosmans JE; Hermens ML; de Bruijne MC; van Hout HP; Terluin B; Bouter LM; Stalman WA; van Tulder MW
J Affect Disord; 2008 Nov; 111(1):106-12. PubMed ID: 18342952
[TBL] [Abstract][Full Text] [Related]
18. Computerised speech and language therapy or attention control added to usual care for people with long-term post-stroke aphasia: the Big CACTUS three-arm RCT.
Palmer R; Dimairo M; Latimer N; Cross E; Brady M; Enderby P; Bowen A; Julious S; Harrison M; Alshreef A; Bradley E; Bhadhuri A; Chater T; Hughes H; Witts H; Herbert E; Cooper C
Health Technol Assess; 2020 Apr; 24(19):1-176. PubMed ID: 32369007
[TBL] [Abstract][Full Text] [Related]
19. Cost effectiveness of a pharmacy-based coaching programme to improve adherence to antidepressants.
Bosmans JE; Brook OH; van Hout HP; de Bruijne MC; Nieuwenhuyse H; Bouter LM; Stalman WA; van Tulder MW
Pharmacoeconomics; 2007; 25(1):25-37. PubMed ID: 17192116
[TBL] [Abstract][Full Text] [Related]
20. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
